RELATIONSHIP BETWEEN CATHEPSIN-D AND OTHER PATHOLOGICAL AND BIOLOGICAL PARAMETERS IN 1752 PATIENTS WITH PRIMARY BREAST-CANCER

被引:32
作者
GION, M
MIONE, R
DITTADI, R
ROMANELLI, M
PAPPAGALLO, L
CAPITANIO, G
FRIEDE, U
BARBAZZA, R
VISONA, A
DANTE, S
机构
[1] OSPED PF CALVI,CTR ONCOL,NOALE,ITALY
[2] OSPED CIVILE,SERV ANAT PATOL,VENICE,ITALY
[3] OSPED UMBERTO 1,SERV ANAT PATOL,MESTRE,ITALY
[4] OSPED CIVILE,SERV ANAT PATOL,MIRANO,ITALY
[5] OSPED BOLDRINI,SERV ANAT PATOL,THIENE,ITALY
[6] OSPED S BORTOLO,DIV ANAT PATOL,VICENZA,ITALY
关键词
CATHEPSIN D; BREAST CANCER; NODAL STATUS; TUMOR SIZE; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROGNOSIS;
D O I
10.1016/0959-8049(94)00532-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between cathepsin D and other pathological or biological prognostic parameters has not yet been defined through systematic studies in breast cancer. The aim of the present investigation was to define the relationship between cathepsin D and nodal status, tumour size, steroid receptors and tumour grade in a wide patient series. Cytosol cathepsin D was assayed with an immunoradiometric assay in tumour samples from 1752 patients. A statistically significant, but not biologically meaningful association was found between cathepsin D and both tumour size and grade. Cathepsin D was significantly higher in node-positive than in node-negative tumours. However, cathepsin D is not of great use in order to predict the risk of axillary metastases in individual patients, due to overlapping of cathepsin D values between node-positive and node-negative cases. A significant, direct association was found between cathepsin D and both oestrogen receptor and progesterone receptor cytosol levels. Nevertheless, preliminary data indicate that cathepsin D and steroid receptors provide independent prognostic information.
引用
收藏
页码:671 / 677
页数:7
相关论文
共 34 条
  • [1] Mittra, MacRae, A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology?, Eur J Cancer, 27, pp. 1574-1583, (1991)
  • [2] Foekens, Peters, Portengen, Noordegraaf, Berns, Klijn, Cell biological prognostic factors in breast cancer: a review, J Clin Immunoassay, 14, pp. 184-195, (1991)
  • [3] Barrett, Cathepsin D and other carboxyl proteinases, Proteinases in Mammalian Cells and Tissues, pp. 209-248, (1977)
  • [4] Garcia, Lacombe, Duplay, Et al., Immunohistochemical distribution of the 52kDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness, J Steroid Biochem, 27, pp. 439-445, (1987)
  • [5] Rochefort, Augereau, Briozzo, Et al., Structure, function, regulation and clinical significance of 52k pro-cathepsin D secreted by breast cancer cells, Biochimie, 70, pp. 943-949, (1988)
  • [6] Rochefort, Capony, Garcia, Et al., Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis?, Journal of Cellular Biochemistry, 35, pp. 17-29, (1987)
  • [7] Garcia, Salazar-Retana, Richer, Et al., Immunohistochemical detection of the estrogen-regulated Mr 52,000 protein in primary breast cancer but not in normal breast and uterus, J Clin Endocrinol Metab, 59, pp. 564-566, (1984)
  • [8] Briozzo, Morisset, Capony, Rougeot, Rochefort, In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells, Cancer Res, 48, pp. 3688-3692, (1988)
  • [9] Vignon, Capony, Chambon, Freiss, Garcia, Rochefort, Autocrine growth stimulation of the MCF breast cancer cells by the estrogen-regulated 52K protein, Endocrinology, 118, pp. 1537-1545, (1986)
  • [10] Thorpe, Rochefort, Garcia, Et al., Association between high concentration of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer, Anticancer Res, 49, pp. 6008-6014, (1989)